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Abstract
For more than 30 years, lipid droplets (LDs) were considered as an inert bag of lipid for storage of 
energy-rich fat molecules. Following a paradigm shift almost a decade ago, LDs are presently 
considered an active subcellular organelle especially designed for assembling, storing and 
subsequently supplying lipids for generating energy and membrane synthesis (and in the case of 
hepatocytes for VLDL secretion). LDs also play a central role in many other cellular functions 
such as viral assembly and protein degradation. Here, we have explored the structural and 
functional changes that occur in hepatic and adipose tissue LDs following chronic ethanol 
consumption in relation to their role in the pathogenesis of alcoholic liver injury.
INTRODUCTION
Alcohol abuse causes more than 60% of all chronic liver diseases and accounts for 2.5 
million deaths globally each year [1]. Approximately 51.5% of US citizens use alcohol 
regularly; nearly 18% of these individuals meet the criteria for alcohol abuse [2]. The 
earliest manifestation of chronic alcohol consumption is the development of alcoholic fatty 
liver disease (AFLD). This is characterized by the intracellular accumulation of lipids that 
are stored in a specialized organelle called lipid droplets (LDs). The development of hepatic 
steatosis (fatty liver) is considered an initial critical event that predisposes the liver to 
progressive inflammation, fibrosis and cirrhosis [3, 4]. Thus, the understanding of the 
intracellular lipid stores and LD metabolism has emerged as a cornerstone for developing 
therapy against hepatic steatosis.
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In this review, we will first present an overview of LD structure and function. This will be 
followed by examining the effects of alcohol administration on various pathways/
mechanisms that are responsible for the loss of adipose tissue LDs and the concomitant 
increase in the accumulation of hepatic LDs. The role of these alterations in the progression 
of liver injury will also be discussed. We will finally present therapeutic intervention 
strategies that prevent changes in adipose tissue and hepatic LDs to ultimately protect 
against the development of AFLD.
GENERAL STRUCTURE, FUNCTION AND METABOLISM OF LDs
LDs are also referred to as adiposomes, lipid bodies, fat bodies, eicosasomes, liposomes or 
even great balls of fat, and in the past decade the field has settled on the preferred name, LDs 
[5, 6]. LDs are highly conserved organelle present from bacteria to mammals [6, 7].
In eukaryotes, LDs may arise primarily from the endoplasmic reticulum (ER) and continue 
to maintain tight association with the parent organelle [6, 8, 9]. Although several models for 
LD formation have been proposed and discussed in details [6, 8, 10–12], none have been 
sufficiently proven. LDs have also been shown to interact with other cell organelles 
including mitochondria, peroxisomes and endosomes [13–18]. Structurally, LDs are 
composed of a homogenous lipid core covered by a phospholipid monolayer studded with 
proteins as discussed below and depicted in Fig. 1.
LD STRUCTURE
LD Core
The hydrophobic core of LDs is made of neutral lipids with tri- and diacylglycerols, 
esterified cholesterol and retinyl esters. These core lipids are present in hepatocyte LDs 
whereas LD cores in adipocytes are mainly triacylglycerol (TAG) [5, 6]. LDs number and 
size varies significantly between different cell types [6]. White adipocytes mainly form one 
giant unilocular LD as large as 100 μm, while most other cell types, including hepatocytes, 
have multiple small LDs with diameters of 100–200 nm [19, 20]. However, the size and 
number of LDs can increase under pathological conditions such as in hepatocytes following 
ethanol administration [21, 22].
LD Surface
LDs are coated by a monolayer of phospholipids, free cholesterol and lysophospholipids. 
LDs have been shown to have a unique phospholipid profile in their monolayer and 
phosphatidylcholine (PC) is the major phospholipid (50–60%) followed by 
phosphatidylethanolamine (PE) and phosphatidylinositol [23]. LDs are shown to have >50 
different types of PC and 45 types of PE, and 9 species of phoshatidylinositol [23]. The 
phospholipids in the coating have been reported to stabilize the droplets and facilitate 
interactions with other cellular compartments and in maintaining LD morphology [24, 25]. 
There are also specific proteins that localize to the surface of LDs. In 1991, Greenberg et al 
identified a novel LD bound phosphoprotein, perilipin, in adipocytes [26]. Soon after, two 
other structurally related LD-binding proteins (ADRP and TIP47) were also identified [5]. 
These three LD-binding proteins became the founding members of the PAT (perilipin, 
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ADRP and TIP47) family of proteins [5]. These proteins have since been renamed 
Perilipin1, 2 and 3 (Plin1-3) respectively. In addition, perilipin4 and perilipin5 (older name 
S3-1 and OXPAT respectively), CG-158, lipases, protein kinases, phosphatases and lipid 
transport proteins associate with LDs and play important roles in regulating LD structure 
and function (reviewed in [9]).
Additional Proteins Associated with LDs
Only a dozen LD-associated proteins had been identified until 2006 when a mass 
spectrometry approach provided an array of proteins that were associated with LDs [5]. 
Subsequent proteomic approaches have revealed a surprising number of proteins, many 
unique, to be present in LDs isolated from different cell types [27–30]. The LD proteome 
was shown to have histone proteins like H2A, H2Av, H2B and vesicular trafficking proteins 
like Rab8 and Rab11 [31]. Further studies identified a repertoire of many other Rab-family 
members like, Rab1, 2, 5, 10, 14, 18,19b, 21, 24, 33b, 34, 35, 39, and 41 in LDs of Chinese 
hamster ovary cells [32].
LDs have been documented to contain enzymes for each step of de novo TAG synthesis [9, 
33] and reportedly have the ability to locally synthesize PC. Lysophosphatidylcholine 
acyltransferase-1 and -2 [34] as well as enzymes that catalyze the rate-limiting step of de 
novo PC synthesis such as CTP:phosphocholine cytidyltransferase-1 and -2 [25, 35] have all 
been localized to LDs.
Earlier LD proteomes were also shown to have cytoskeletal, ER, lysosomal, mitochondrial, 
golgi, and chaperone proteins [32] which suggested that LDs could act as a carrier of 
proteins [31]. However, whether these other organelle proteins in the LD proteome represent 
co-purified contaminating or authentic LD proteins is currently being sorted out by utilizing 
protein correlation profile studies [35]. The various proteins present or associated with the 
LDs regulate key LD functions and are linked to many physiological processes as recently 
reviewed [6, 9, 14, 36–41].
LD FUNCTION AND METABOLISM
LDs have been shown to perform many cellular functions (Fig. 2), including storage, 
transport, and metabolism of lipids, viral assembly, protein sequestration, membrane 
trafficking and signaling [6, 8, 10, 11, 18, 33, 35, 42, 43].
In the healthy liver, the number and size of LDs are tightly regulated and there is an 
orchestrated re-distribution of stored TAG following lipolysis. FAs liberated from TAGs in 
liver LDs have one of several fates. They can be used as building blocks for membrane lipid 
synthesis, used for β-oxidation to generate energy or exported to the ER for re-esterification 
and packaging into VLDL for secretion [44]. These latter two mechanisms are used by the 
liver to get rid of the fat and prevent generation of steatosis.
LD Lipolysis and Associated Lipases
LDs were initially thought to be degraded extensively by hormone sensitive lipase (HSL) in 
adipocytes and in the liver. However, the failure of HSL knockout mice to become obese 
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indicated that other lipase(s) are present that can compensate for HSL deficiency [45, 46]. 
Later, two independent groups identified adipose triglyceride lipase (ATGL) on LDs [47, 48] 
that co-localized with Plin2 and Plin3 [49]. It has been documented that ATGL and Plin2 are 
both delivered to LDs from ER via COPI and COPII coatomer protein-mediated pathways 
[50]. ATGL-deficient mice exhibit LD accumulation in many tissues examined [48, 51, 52]. 
Despite low ATGL expression in the liver [53], (liver-specific) deficiency of this lipase 
caused increased LD accumulation in hepatocytes and cholangiocytes [54, 55]. Conversely, 
overexpression of ATGL enhanced LD lipolysis causing a marked decrease in LD size and 
this appeared to occur through displacement of Plin3 from LDs [49]. HSL overexpression 
also resulted in the loss of LDs [56]. However, ATGL or HSL overexpression did not 
promote VLDL assembly; instead it improved mitochondrial fatty acid β-oxidation [56]. 
These results are consistent with ATGL and HSL playing a role in lipid catabolism rather 
than VLDL export. A lipase that functions in mobilizing liver lipids for VLDL secretion is 
triacylglycerol hydrolase (TGH), which primarily resides in the ER [53] and also associates 
with LDs [57].
Patatin-like phospholipid domain containing protein 3 (PNPLA3), a multifunctional enzyme 
encoded by the PNPLA3 gene, has been shown to accumulate on LDs under pathological 
conditions [58]. PNPLA3 and their family members have patatin-like domain at the N-
terminus for the lipase activity [59] and a conserved brummer box domain that helps 
targeting to LDs [59]. PNPLA3 also reportedly possesses acylglycerol O-acyltransferase 
activity that mediates the conversion of lysophosphatidic acid into phosphatidic acid [60].
In addition to its lipase activity, PNPLA3 was also shown to interact with another family 
member of patatin-like domain containing lipase, PNPLA2, and functions as a co-activator 
for enhancing PNPLA2 lipase enzyme activity [59].
LDs and VLDL Assembly
The assembly of VLDL is regulated by the availability of TAGs stored in cytoplasmic LDs 
[61]. Up to 70% of TAGs in VLDLs are derived via lipolysis and re-esterification of 
preformed TAG stores in LDs [62–64]. While the exact mechanism that links the 
composition of a VLDL core to LD lipolysis is not yet known, the formation of LDs in the 
secretory pathway clearly plays a central role in VLDL assembly and secretion. The protein 
and lipid factors within LDs must be maintained in a delicate balance for effective lipolysis. 
Any change in the structure or interactions of these components can alter the strong 
relationship between the accumulation of LDs and the rate of formation of VLDL. A 
potentially important observation is that the relative distribution of PC or PE modifies the 
LD size [23]. It has been documented that changes in the phospholipid composition can 
promote LDs to fuse into supersized structures that appear to be resistant to normal lipolysis 
[65, 66]. PE is a conical lipid that can increase membrane curvature, thereby promoting 
membrane fusion [24, 67]. Interestingly, an increase in the LD content of PE in absolute and 
relative terms at the expense of PC coincides with the accumulation of LDs [67].
Phosphatidylethanolamine methyltransferase (PEMT) is an enzyme that is required for 
normal secretion of VLDL as it is involved in synthesis of PC moieties that are preferentially 
used for the VLDL synthesis [68]. We contend that this enzyme is also important for 
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maintaining PC on hepatic LDs, thereby, preventing the development of supersized LDs that 
are resistant to lipolysis. Conversely, PEMT in adipocytes has been postulated to stabilize 
LD structures and promote fat deposition [67, 68].
LDs and Autophagy
Autophagy is mostly a cell survival mechanism providing a source of energy during nutrient 
starvation by catabolizing cellular proteins. Recent studies have revealed the role of 
autophagy in preventing LD accumulation [69]. Autophagy occurs by forming double-
membrane autophagosomes which fuses to lysosomes resulting in degradation by lysosomal 
proteases and lipases [70]. Inhibition of autophagy, either by using 3-methyl adenine or by 
knocking down Atg2, Atg6, Atg7, & Atg8 genes, resulted in an increased accumulation of 
LDs in hepatocytes as well as decreased VLDL secretion [69, 71]. Further, co-localization of 
the autophagic marker protein, LC3, with LDs suggested that these two are physiological 
interacting partners [69]. A recent study identified that the LD-associated proteins, Plin2 and 
Plin3, are degraded by chaperone-mediated autophagy [72]. Further, these Plins possess a 
putative pentapeptide motif that is recognized by heat shock cognate protein of 70kDa 
(hsc70) for their delivery to the lysosomal-associated membrane protein 2A (LAMP-2A), a 
lysosomal surface protein [72]. Plin2 mutants that cannot bind to hsc70 were shown to be 
enriched in larger sized LDs [72]. Moreover, hepatocytes and fibroblast isolated from 
LAMP-2A deficient mouse exhibit increases in LDs and TAG levels [72]. Taken together, 
accumulating evidence indicates that lipophagy (a term for autophagy related to controlling 
lipid levels) and chaperone-mediated autophagy of Plin2 and Plin3 may play an important 
role in preventing LD accumulation in the liver by promoting lipolysis and VLDL secretion 
[73–76].
Vesicular trafficking of LDs in Hepatocytes
Our laboratories have made valuable contributions toward understanding the trafficking 
network in hepatocytes [77–79]. Current work in our laboratories is examining roles of 
several proteins involved in vesiculation (Dynamin-2; Caveolin-1 and Src) and transport 
(Rab18 and Rab7) relevant to LD trafficking.
Dynamin-2 (Dyn-2), Caveolin-1 (Cav-1) and Src kinase (Src)—Dyn-2 is a large 
GTPase that is known to polymerize around the neck of membrane invaginations for 
constricting, severing (“pinch”) and releasing a newly formed, small vesicle [78]. Our recent 
observations implicate Dyn-2 in LD vesiculation and metabolism [80]. Specifically, we have 
shown that knockdown or inhibition of Dyn-2 results in increased LD accumulation in liver 
cells [80]. We also demonstrated that Dyn-2 plays an important role in lipophagic 
breakdown [80]. Dyn-2 works in concert with two other proteins, Cav-1, a coat protein, and 
Src, a tyrosine kinase. Cav-1 is known to bind cholesterol, is targeted to LDs by exogenous 
cholesterol and associates with LDs [81–83]. Importantly, Cav-1 and Dyn-2 are regulated by 
Src [84, 85]. However, the participation of these three proteins in LD dynamics and 
metabolism is currently not known.
Rab proteins—An extensive family of small GTPases named Rab proteins act as 
molecular switches to support the targeted transport, docking, and fusion of a donor vesicle 
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to a receptor compartment. Several Rab proteins have been identified on LDs [22, 31, 32], 
and two of these are particularly important in LD metabolism. Rab18 is a common mediator 
in both lipogenesis and lipolysis [86] and co-localizes with Plin1 and Plin2 in the LDs 
isolated from hepatic cells [87]. Rab7 is known to play an important role in lipophagy [88]. 
We have recently observed that starvation enhances the level of active Rab7 in the LD 
fraction and suggested that this increase of active Rab7 in LD favors lipolysis [89]. 
Additionally, activated Rab7 in LDs is critical for LD interaction with multivesicular bodies 
and lysosomes and in the formation of autophagolysosomes [89]. LDs associated Rab7 was 
also found to be decreased in LAMP-2A deficient cells suggesting the important role of 
Rabs and chaperone-mediated autophagy in LD metabolism [72].
LD and Hepatitis C Virus Assembly
Many viruses, such as hepatitis C virus (HCV), use host cell LDs for replication [90]. 
Indeed, LDs are directly involved in assembling the infectious HCV particles. It has been 
shown that the maturation of the core protein promotes the transport of this structural HCV 
protein from the ER to the surface of LDs, where the full infectious particle is assembled 
[91]. While the exact mechanism of recruitment of core protein to LDs is not clear, it has 
been shown that trafficking of core to LD involves Rab18 [92]. The localization of HCV 
core protein to LD depends on the host diacylglycerol acyltransferase-1, which plays a 
pivotal role in translocation and attachment of core protein to LD [93]. Recently, it has been 
reported that the presence of core at the surface of LDs also interferes with the activity of 
ATGL, thereby blocking lipolysis [94].
Following core protein attachment to LDs, non-structural proteins and replication complex 
are recruited to these LDs [95] which through multiple protein-protein interactions [96] 
coordinate viral assembly [97]. In addition to providing a surface for viral assembly, LD also 
provides a vesicular transport system for virus to be exported out of the infected cells [98].
MicroRNAs in LD Metabolism
MicroRNAs (miRs) act to fine-tune the expression of a large number of genes and can 
regulate cell physiology and pathology. Emerging evidence implicates miRs in LD 
formation, lipid catabolism and vesicular trafficking. Functionally, miRs have been shown to 
alter LD formation in a “spontaneous steatosis” cell model. Specifically, a panel of 327 miRs 
was transfected into Huh7 cells followed by automated imaging (high-content analysis) to 
measure LD content. Six miRs (miR-34c, miR-509, miR-29a, miR-515-5p, miR-378, 
miR-1) were shown to increase LD accumulation while five miRs (miR-181d, miR324, 
miR-451, miR-493-5p, miR-135a) decreased lipid accumulation [99]. The specific 
functional importance of these results remains to be defined.
CHANGES IN HEPATIC LD STRUCTURE, FUNCTION AND METABOLISM 
FOLLOWING ETHANOL ADMINISTRATION
The first pathological change that occurs during the early stages of AFLD is increased 
accumulation of LDs within hepatocytes [100, 101]. Many of the detrimental effects of 
alcohol on the liver, including LD accumulation, are dependent on alcohol metabolism [102–
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104]. Alcohol oxidation primarily occurs via two enzymes, alcohol dehydrogenase and 
microsomal cytochrome p450-2E1 that generate acetaldehyde [102, 103]. This toxic 
metabolite is a key player in the pathogenesis of AFLD since preventing its generation 
significantly attenuates LD accumulation in alcohol-metabolizing hepatic cells [104] and the 
development of many features of alcoholic liver injury.
There are characteristic compositional changes in hepatic LDs following ethanol 
administration, as reviewed below, that collectively play a role in altering LD metabolism 
and promoting the pathogenesis of alcoholic liver injury.
Role of Plin2
An increase in Plin2 has been suggested to be a reliable diagnostic marker for excessive 
alcohol consumption [21, 105]. There is a direct correlation between hepatic LDs and Plin2 
levels and LDs number and size increase in parallel with the induction of Plin2 expression 
[21, 104–106].
Increasing Plin2 expression significantly blocked TAG hydrolysis and increased the fraction 
of cellular TAG that was stored in LDs [21, 107]. This anti-lipolytic effect of Plin2 to slow 
TAG turnover is mediated via its role in impairing ATGL association with LDs [107]. 
Conversely, Plin2 depletion prevented the alcohol-induced LD accumulation [108] 
indicating an important role of Plin2 in the pathogenesis of alcoholic steatosis.
Role of PNPLA3
Genome-wide association studies have identified variants of PNPLA3 in AFLD [109–112]. 
A common PNPLA3 I148M variant impaired hepatic secretion of VLDL and caused 
accumulation of TAG and cholesterol esters in large LDs of hepatocytes [113]. This 
observed effect could be explained by a recent report that, unlike recombinant enzyme, 
mutant PNPLA3 form does not display any TAG hydrolase activity [114]. However, 
PNPLA3 I148M variant showed 2.1 fold higher acylglycerol O-acyltransferase activity and 
this biochemical gain function were suggested to promote liver steatosis in the carriers of 
this variant [60]. Interestingly, a search in yeast mutants which produced supersized LDs 
were all shown to have dysregulated phospholipid metabolism and more commonly 
exhibited increased phosphatidic acid levels [115].
A recent study demonstrated that PNPLA3 is highly expressed in hepatic stellate cells 
(HSC) and further revealed that its lipase activity was responsible for degrading the stored 
retinoids in LDs of these cells [116]. Activation of HSC and the loss of stored retinoids is an 
initial event in the fibrotic process [117, 118] and alcohol administration impaired the 
activities of several retinoid metabolic enzymes [119]. However, further lipidomics analyses 
of retinoic esters in the hepatocyte and HSC LDs are needed to understand the metabolism 
of retinoid and their role in the pathogenesis of alcoholic liver injury.
Role of Altered Rab Protein Content and Impaired Vesicular Trafficking
Recent studies from our laboratories have shown alterations in several small GTPases 
involved in both vesicle and LD trafficking after ethanol administration [22]. Isolated LDs 
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from ethanol-fed rat livers identified significantly decreased protein content of Rab2, 5, 7, 
and 18 compared to controls [22]. Of particular interest was the observed decrease in Rab7 
and Rab18 GTPases as both these proteins significantly affect LD metabolism as discussed 
below.
Rab18—Rab18 is a well characterized trafficking protein believed to be functionally 
important in LD biology, especially as it relates to lipolysis and LD accumulation. After 
identifying the decrease in Rab18 content on LDs from ethanol-fed rats, we evaluated its 
precise localization and interaction(s) with other LD proteins [22]. We observed that Rab18 
was present on all LDs and it co-localized with Plin2 in the livers from control-fed animals 
[22]. In contrast, not all the LDs were found to be coated with Rab18 in the livers from 
ethanol-fed animals [22]. This was especially apparent in the large LDs, where the co-
localization between Rab18 and Plin2 was significantly decreased. These data are 
particularly intriguing since previous research showed that Rab18 was recruited to LDs upon 
lipolytic stimulation [87]. We believe that the impaired recruitment of Rab18 to LDs and the 
decreased association of Rab18 with the anti-lipolytic Plin2, [107] following ethanol 
administration may be directly responsible for the reduced lipolysis and consequent LD 
accumulation.
Rab7—We have identified decreased Rab7 on LDs isolated from ethanol-fed rats [22], and 
data shows that Rab7 plays an important role in lipophagy [88]. Specifically, it has been 
observed that starvation enhances the level of active Rab7 in the LD fraction suggesting that 
increased active Rab7 in LD favors lipolysis [89]. Since activated Rab7 in LDs is critical for 
LD interaction with multivesicular bodies and lysosomes for the formation of 
autophagolysosomes, it is tempting to speculate that ethanol-induced LD accumulation in 
the liver might be a consequence of decreased lipophagy due to the impaired association of 
active Rab7 with LDs.
Role of Alterations in Liver Lipids and Phospholipids
Lipid analysis with alcohol consumption reported an elevation of 22:6, 18:0 and 18:0 to 18:3 
FA containing lipids in serum and liver of alcohol-fed mice [120, 121]. Lipidomic studies 
using pattern recognition analysis of nuclear magnetic resonance spectroscopic data revealed 
that PC and total fatty acyl chains were decreased in the alcohol-fed liver [122]. Recent 
studies employing LD lipidomics revealed increases in TAGs, cholesterol, monounsaturation 
of fatty acyl chains, free FAs and significant decreases in PC levels in isolated LDs from the 
ethanol-fed rats compared with controls [123–125]. It is yet to be demonstrated whether 
such decrease in PC on LD surface could potentially causes impaired lipolysis, reduced TAG 
turnover and impaired VLDL secretion.
Ethanol administration has been shown to decrease the activity of microsomal long chain FA 
elongase 5 (Elovl5) [126]. Interestingly, adenoviral induction of hepatic Elovl5 was shown 
to promote lipolysis by increasing ATGL mRNA and protein expression [127]. Whether 
such ethanol-induced decrease in Elovl5 also is affecting ATGL expression and hepatic TAG 
turnover is another area of research that warrants further investigation.
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Role of Lipophagy
Recent studies have shown that ethanol administration in addition to causing lipid 
accumulation in the liver also upregulates autophagic clearance of LDs as a protective 
measure [17, 71, 128, 129]. Acute ethanol-induced autophagy was also shown to enhance 
the clearance of damaged or fragmented mitochondria, a process termed as mitophagy [71]. 
Mitophagy can decrease the generation of reactive oxygen species and thereby functions as a 
protective mechanism to reduce ethanol-induced hepatotoxicity [71]. Signaling mechanism 
of ethanol-induced autophagy is via the inhibition of Akt and mammalian target of 
Rapamycin [71, 128].
Autophagy was also shown to be directly dependent on ethanol metabolism and reactive 
oxygen species generation [71]. Supplementation with antioxidants decreases ethanol-
induced autophagy [71]. While ethanol-induced hepatocyte apoptosis has been shown to be 
very minimal [130], inhibition of autophagy resulted in increased hepatocyte apoptosis. 
These results suggest that the ethanol-mediated induction of the autophagic process is a 
protective, cell survival mechanism [131]. In support of this protective role of autophagy, 
liver specific autophagy-related protein 7 (Atg7) knockdown mice exposed to binge alcohol 
exhibit more severe liver damage [132]. Similarly, silencing Atg5 resulted in an increase in 
hepatocyte apoptosis [131, 132]. Conversely, treatment with rapamycin, an autophagy 
inducer, lowers LDs accumulation and triglyceride levels [133, 134]. Further investigations 
are required to examine whether an autophaghic inducer can promote LD catabolism and be 
used for reversing alcohol-induced hepatic steatosis.
Role in HCV Assembly
While there are no published studies on the role of ethanol on LD-associated HCV assembly, 
we believe that ethanol-induced increased LD accumulation could be responsible for the 
faster progression of the infection and in the exacerbation of liver injury in HCV-infected 
alcoholic patients. Indeed, we have observed an increased accumulation of LDs in livers of 
HCV ethanol-fed core-transgenic mice (unpublished observations) and in the livers of 
ethanol-fed NS5A+ mice [135]. Ongoing investigations are in progress to understand the 
persistence of HCV infection in alcoholic patients and their poor response to anti-viral 
therapy.
MiRs in LD metabolism
Excellent review articles discussing ethanol-induced alterations in miRs and their role in 
pathogenesis of liver injury have been published recently [136, 137]. However, the mode of 
ethanol delivery by oral feeding or gavage appears to modulate miRs differently [138, 139]. 
More work is needed to dissect and understand the relevance of these observations in disease 
progression. Nevertheless, especially relevant to alcoholic steatosis is the observation that 
ethanol administration increased hepatic miR-33 expression and decreased VLDL secretion 
[140]. Whether therapeutic approaches to alter miRs could limit LD formation and liver 
injury remains to be seen.
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THERAPEUTIC ROLE OF BETAINE
A variety of animal model studies [141, 142] and in vitro studies [143–145] by many 
investigators have shown that treatment with betaine can mitigate many hallmark features of 
alcoholic liver injury [146, 147] including alcoholic steatosis [142]. More importantly, 
betaine protection against the development of ALFD is mediated via its effect on LDs. 
Particularly, the ethanol-induced increases in the size and numbers of LDs in the 
centrilobular and mid zonal regions of the liver lobules are prevented by betaine 
administration [148].
Mechanistic studies conducted in our laboratories have implicated the alcohol-induced 
reduction in the hepatocellular S-adenosylmethionine (SAM) to S-adenosylhomocysteine 
(SAH) ratio [142, 144] impairs PEMT-catalyzed PC generation [142, 144]. This in turn, 
causes decreased VLDL secretion [149], contributing to increased fat accumulation in the 
liver [142]. We have further shown that betaine treatment normalizes PEMT-catalyzed-PC 
generation [142] that restores VLDL secretion rate [149] and prevent alcohol-induced LD 
accumulation and steatosis [142, 148]. Whether PEMT-mediated catalysis is also responsible 
for maintaining LD surface PC moieties and in promoting lipolysis and TAG turnover for 
VLDL production and secretion is currently being examined.
CHANGES IN ADIPOCYTE LDs AFTER ETHANOL ADMINISTRATION
Emerging evidence suggests that an impaired adipose-liver tissue axis can be a potential 
factor that affects hepatic fat overload observed in alcoholics [150–153]. White adipose 
tissue (WAT) is the main site to store excess nutrients in the form of LDs and recent 
metabolic tracing experiments have shown that ethanol enhances adipocyte lipolysis, thereby 
shifting the metabolic task of storing excess lipids in the liver [150, 152]. Indeed, ethanol-
induced WAT loss in the three main abdominal (epididymal, perirenal and mesenteric) fat 
storing sites [150] occurs through activation of lipases, HSL and ATGL [150, 152]. ATGL 
activity is normally inhibited by insulin [154] and it has been suggested that insulin 
resistance that develops with chronic ethanol abuse could mechanistically be related to 
increased WAT lipolysis [152]. Further ethanol-induced oxidative stress [155, 156] can also 
induce ATGL expression in a FoxO1-dependent manner [157].
Further studies have reported that alcohol-induced decreases in the adipose SAM:SAH ratio 
and elevations in homocysteine levels [155, 156, 158, 159] enhances HSL activation to 
promote LD lipolysis [158–160]. More importantly, betaine exerts it therapeutic effect to 
facilitate TAG storage in adipocytes by preventing these ethanol-induced changes in adipose 
tissue [158, 159].
CONCLUSIONS
Here we have presented details on the general structure of LDs and the associated proteins 
that control many cellular functions of LDs (Fig. 3), including storage, transport, and 
metabolism of lipids and HCV assembly. We discussed the structural and functional 
alterations that occur in adipocytes and hepatocytes LDs following ethanol administration. 
We further presented some insights into how these compositional changes promote lipolysis 
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and LD loss in adipocytes (Fig. 4) and at the same time inhibit lipolysis and TAG turnover in 
hepatocyte LDs to impair VLDL production and secretion (Fig. 5), ultimately leading to the 
development of AFLD. Finally, we presented a therapeutic option of using betaine that 
ameliorates both ethanol-induced increases in adipose tissue lipolysis and hepatic LD 
accumulation and thereby prevents the development of ALFD [148, 158, 159].
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Figure 1. Diagrammatic Structure of Lipid Droplets
Lipid droplets (LDs) are composed of a homogenous lipid core covered by a monolayer 
coating of phospholipids, free cholesterol and lysophospholipids. The hydrophobic core of 
LDs is made of neutral lipids with tri- and diacylglycerols, esterified cholesterol and retinyl 
esters. The surface of LDs is also studded with several different proteins including perilipins 
and RabGTPase’s.
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Figure 2. Diverse functions of Liver Lipid droplets
Lipid droplet (LD) is an active subcellular organelle that performs many cellular functions in 
the liver as shown.
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Figure 3. Schematic representation of many players that regulate lipid droplet formation and 
degradation
The protein and lipid factors within lipid droplets (LDs) must be maintained in a delicate 
balance for effective lipolysis. Any change in the structure or interactions of these 
components can alter lipid droplet formation and their degradation. Hepatic 
phosphatidylethanolamine methyltransferase (PEMT) maintains phospholipids composition 
of the LD for normal lipolysis to facilitate VLDL production and secretion to ultimately 
prevent LD accumulation. In addition, lipases, active RabGTPases such as Rab7 and 
dynamin 2 activate lipolysis/vesiculation and prevent LD accumulation. LD also recruits 
core autophagic machinery and LAMP-2A dependent chaperone-mediated autophagy of 
Perilipin2 (Plin2) thereby favoring lipolysis. Several microRNAs (miRs) listed reportedly 
prevent LD accumulation. Alternatively, several other miRs, Plin2 and HCV proteins all 
promote LD accumulation in the liver.
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Figure 4. Major mechanisms by which ethanol promotes adipocyte LD lipolysis
Ethanol induces LD lipolysis in white adipose tissue (WAT) loss through activation of the 
lipases (HSL and ATGL). Insulin resistance that develops with chronic ethanol abuse 
promotes WAT LD lipolysis via ATGL activation. Further ethanol-induced oxidative stress 
also induces ATGL expression in a FoxO1-dependent manner. Ethanol-induced changes in 
adipose S-adenosylmethionine:S-adenosylhomocysteine (SAM:SAH) ratio enhance HSL 
activation to promote LD lipolysis. Betaine can prevent activation of the lipases via 
normalizing adipose SAM:SAH ratios and preventing homocystenemia.
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Figure 5. Multiple mechanisms by which ethanol facilitates lipid droplet accumulation in the 
liver
In the healthy liver, the number and size of lipid droplets (LDs) are tightly regulated and 
there is an orchestrated re-distribution of stored triglycerides (TAG) following lipolysis. 
Ethanol-induced changes in LD phospholipid and protein composition inhibits LD lipolysis, 
TAG turnover and VLDL secretion causing LD accumulation in the liver. Betaine via its 
ability to normalize hepatocellular methylation potential (S-adenosylmethionine:S-
adenosylhomocysteine [SAM:SAH] ratio) could normalize LD phospholipid composition to 
promote lipolysis and VLDL secretion, thereby preventing LD accumulation.
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